PHATHOM PHARMACEUTICALS, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $91.0M | $38.0M | $138.1M |
| Jun 2022 | $92.4M | $-7.0M | $207.4M |
| Sep 2022 | $93.9M | $-26.4M | $196.8M |
| Dec 2022 | $95.3M | $-74.8M | $155.4M |
| Mar 2023 | $96.6M | $-90.2M | $129.6M |
| Jun 2023 | $97.8M | $17.6M | $248.8M |
| Sep 2023 | $99.3M | $-17.8M | $213.7M |
| Dec 2023 | $137.8M | $-72.8M | $381.4M |
| Mar 2024 | $149.0M | $-148.5M | $322.2M |
| Jun 2024 | $174.4M | $-233.8M | $276.2M |
| Sep 2024 | $175.7M | $-187.1M | $334.7M |
| Dec 2024 | $201.4M | $-253.6M | $297.3M |
| Mar 2025 | $203.2M | $-338.4M | $212.3M |
| Jun 2025 | $205.1M | $-405.8M | $149.6M |
| Sep 2025 | $207.1M | $-422.5M | $135.2M |
| Dec 2025 | $209.1M | $-438.2M | $130.0M |
| Mar 2026 | $163.7M | $-337.0M | $180.9M |
| Jun 2026 | $164.6M | $-344.3M | $182.5M |